We are live on ! Find out more
ACA

Aptus Capital Advisors Portfolio holdings

AUM $12.7B
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
-6.99%
1 Year Est. Return
+17.41%
3 Year Est. Return
+53.41%
5 Year Est. Return
+57.81%
10 Year Est. Return
AUM
$379M
AUM Growth
Cap. Flow
+$395M
Cap. Flow %
104.3%
Top 10 Hldgs %
60.39%
Holding
174
New
174
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 4.99%
2 Technology 4.9%
3 Consumer Discretionary 4.82%
4 Industrials 3.43%
5 Financials 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRSK icon
1
Aptus Defined Risk ETF
DRSK
$1.51B
$46.1M 12.17%
+1,849,186
New +$47.1M
IEF icon
2
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$43.6M 11.51%
+418,789
New +$42.4M
FTVA
3
DELISTED
Aptus Fortified Value ETF
FTVA
$32.6M 8.61%
+1,379,873
New +$36.4M
SHY icon
4
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$23.4M 6.16%
+279,402
New +$23.2M
SPYM
5
State Street SPDR Portfolio S&P 500 ETF
SPYM
$159B
$18.3M 4.83%
+626,755
New +$19.8M
OSCV icon
6
Opus Small Cap Value ETF
OSCV
$704M
$10.6M 2.79%
+488,002
New +$11.5M
IBDM
7
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
$8.75M 2.31%
+359,221
New +$8.71M
IBDP
8
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$8.75M 2.31%
+365,986
New +$8.73M
IBDO
9
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$8.75M 2.31%
+361,596
New +$8.71M
IBDL
10
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
$8.74M 2.31%
+349,925
New +$8.74M
IBDR icon
11
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.47B
$8.73M 2.3%
+379,132
New +$8.71M
IBDN
12
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
$8.72M 2.3%
+360,688
New +$8.72M
IBDQ
13
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$8.71M 2.3%
+369,231
New +$8.73M
SPAB icon
14
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.6B
$6.95M 1.83%
+249,663
New +$6.86M
SPDW icon
15
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.6B
$5.73M 1.51%
+216,585
New +$6.1M
CI icon
16
Cigna
CI
$74.5B
$2.3M 0.61%
+12,131
New +$2.53M
NVR icon
17
NVR
NVR
$17.5B
$1.8M 0.47%
+739
New +$1.75M
GNTX icon
18
Gentex
GNTX
$5.19B
$1.75M 0.46%
+86,475
New +$1.81M
ABBV icon
19
AbbVie
ABBV
$450B
$1.68M 0.44%
+18,212
New +$1.6M
PFE icon
20
Pfizer
PFE
$143B
$1.66M 0.44%
+40,166
New +$1.67M
CRI icon
21
Carter's
CRI
$1.4B
$1.63M 0.43%
+20,038
New +$1.82M
KLAC icon
22
KLA
KLAC
$278B
$1.61M 0.43%
+180,060
New +$1.68M
AMGN icon
23
Amgen
AMGN
$198B
$1.61M 0.42%
+8,272
New +$1.61M
FFIV icon
24
F5
FFIV
$23.1B
$1.6M 0.42%
+9,865
New +$1.69M
HRB icon
25
H&R Block
HRB
$5.33B
$1.59M 0.42%
+62,552
New +$1.67M

Similar funds

Aptus Capital Advisors's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Aptus Capital Advisors, which disclosed 174 positions worth $379M. Its ten largest holdings account for 60% of the portfolio.

Its largest position is Aptus Defined Risk ETF: 1,849,186 shares worth $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 5% of assets, followed by Technology and Consumer Discretionary.

  • Aptus Capital Advisors's largest Q4 2018 buy was Aptus Defined Risk ETF: 1,849,186 shares worth $46.1M.
  • Aptus Capital Advisors's ten largest holdings make up 60% of its $379M portfolio in Q4 2018.
  • Aptus Capital Advisors disclosed 174 positions in Q4 2018, its first 13F filing on record.

Based on Aptus Capital Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.